Key Takeaways Moderna and other vaccine stocks fell Monday after the Food and Drug Administration's vaccine chief, Peter ...

The drug industry offered its first significant sign of pushback against the Trump administration late Tuesday, after a day ...

Pfizer (NYSE:PFE) and other pandemic-era favorites will be back in the investors’ crosshairs following the resignation of Dr.

The health agency’s top immunization official announced the move Monday in protest, citing Secretary Kennedy’s ‘misinformation and lies.’ Stocks of major vaccine makers dropped on Monday after the ...

The Food and Drug Administration’s top vaccine official, Peter Marks, resigned on Friday, citing what he called Health and ...

Robert F. Kennedy Jr. is set to significantly cut the size of HHS, reshaping the nation’s health agencies and closing ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

U.S. drugmaker shares fell after the FDA's top vaccine official, Peter Marks, was forced to resign. Concerns grow over ...

Robert F. Kennedy Jr.'s confirmation as Secretary of Health and Human Services has raised questions about future healthcare policy. However, Pfizer's foundation remains solid, based on strong cash ...